0000921895-19-000500.txt : 20190214
0000921895-19-000500.hdr.sgml : 20190214
20190214215546
ACCESSION NUMBER: 0000921895-19-000500
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190211
FILED AS OF DATE: 20190214
DATE AS OF CHANGE: 20190214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COUCHMAN JONATHAN
CENTRAL INDEX KEY: 0001265094
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 19609679
MAIL ADDRESS:
STREET 1: 630 FIFTH AVENUE
STREET 2: SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Couchman Family Fund
CENTRAL INDEX KEY: 0001737322
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 19609680
BUSINESS ADDRESS:
STREET 1: 630 FIFTH AVENUE, SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: (212) 729-4962
MAIL ADDRESS:
STREET 1: 630 FIFTH AVENUE, SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xstelos Corp.
CENTRAL INDEX KEY: 0001571659
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36435
FILM NUMBER: 19609681
BUSINESS ADDRESS:
STREET 1: 630 FIFTH AVENUE
STREET 2: SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 212.729.4962
MAIL ADDRESS:
STREET 1: 630 FIFTH AVENUE
STREET 2: SUITE 2260
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000727510
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222372868
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 COMMERCE DRIVE, SUITE 135
CITY: CRANFORD
STATE: NJ
ZIP: 07016
BUSINESS PHONE: 732-980-4500
MAIL ADDRESS:
STREET 1: 20 COMMERCE DRIVE, SUITE 135
CITY: CRANFORD
STATE: NJ
ZIP: 07016
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060324
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20021211
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20021210
4
1
form407216001_02142019.xml
OWNERSHIP DOCUMENT
X0306
4
2019-02-11
0
0000727510
ENZON PHARMACEUTICALS, INC.
ENZN
0001265094
COUCHMAN JONATHAN
630 FIFTH AVENUE
SUITE 2260
NEW YORK
NY
10020
0
0
1
0
0001737322
Couchman Family Fund
630 FIFTH AVENUE, SUITE 2260
NEW YORK
NY
10020
0
0
1
0
0001571659
Xstelos Corp.
630 FIFTH AVENUE
SUITE 2260
NEW YORK
NY
10020
0
0
1
0
Common Stock, $0.01 par value
2019-02-11
4
P
0
15500
0.25
A
4697166
D
Common Stock, $0.01 par value
2019-02-11
4
P
0
10000
0.25
A
4707166
D
Common Stock, $0.01 par value
2019-02-11
4
P
0
500
0.25
A
4707666
D
Common Stock, $0.01 par value
2019-02-11
4
P
0
10000
0.25
A
4717666
D
Common Stock, $0.01 par value
2019-02-11
4
P
0
10000
0.25
A
1569523
I
By Xstelos Corp.
Common Stock, $0.01 par value
2019-02-11
4
P
0
5000
0.25
A
1574523
I
By Xstelos Corp.
Common Stock, $0.01 par value
400000
I
By Couchman Family Fund
This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation") and Xstelos Corp. ("Xstelos" and, together with Mr. Couchman and the Foundation, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose.
Represents Shares owned directly by Xstelos. Mr. Couchman is the controlling shareholder and Chief Executive Officer of Xstelos. By virtue of these relationships, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Xstelos. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
Represents Shares owned directly by the Foundation. Mr. Couchman is the sole trustee of the Foundation. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by the Foundation, however he has no pecuniary interest in such Shares.
/s/ Jonathan Couchman
2019-02-14
Couchman Family Fund; By: /s/ Jonathan Couchman, Trustee
2019-02-14
Xstelos Corp.; By: /s/ Jonathan Couchman, Chief Executive Officer
2019-02-14